SCYNEXIS, Inc.
SCYX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $0 | $1 |
| % Growth | -75.5% | 430.7% | -73.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $0 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $5 | $7 | $5 | $4 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $4 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $11 | $9 | $9 |
| Operating Income | -$8 | -$10 | -$9 | -$8 |
| % Margin | -2,516.5% | -701% | -3,350.2% | -824.3% |
| Other Income/Exp. Net | -$0 | $3 | $3 | $4 |
| Pre-Tax Income | -$9 | -$7 | -$5 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$7 | -$5 | -$4 |
| % Margin | -2,572.2% | -504.8% | -2,097.7% | -453.7% |
| EPS | -0.17 | -0.14 | -0.11 | -0.12 |
| % Growth | -21.4% | -27.3% | 8.3% | – |
| EPS Diluted | -0.17 | -0.14 | -0.11 | -0.12 |
| Weighted Avg Shares Out | 50 | 50 | 49 | 38 |
| Weighted Avg Shares Out Dil | 50 | 50 | 49 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $8 | $10 | $9 | $0 |
| EBITDA | -$0 | $3 | $3 | -$4 |
| % Margin | -55.7% | 196.2% | 1,319.8% | -382.3% |